On October 26th, Gelon Medical (603716.SH) released its third quarter report of 2023, with operating income of 519 million yuan during the reporting period, down 15.34% from the same period last year; net profit belonging to shareholders of listed companies-5.3452 million yuan; net profit belonging to shareholders of listed companies after deducting non-recurrent gains and losses-5.1558 million yuan; basic earnings per share-0.03 yuan per share.
塞力医疗(603716.SH)：第三季度净亏损534.52万元
Seri Healthcare (603716.SH): Net loss of 5.345,200 yuan in the third quarter
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.